Kura Oncology Standard Deviation
| KURA Stock | | | USD 9.32 -0.24 -2.51% |
The Standard Deviation is a measure of how spread out the prices or returns of an asset are on average. It is the most widely used risk indicator in the field of investing and finance. Standard Deviation is commonly used to measure confidence in statistical conclusions regarding certain equity instruments or portfolios of equities. Below is Kura Oncology's current Standard Deviation with peer comparisons and related risk metrics.
Current Standard Deviation Value
The Standard Deviation of 2.97 for Kura Oncology indicates moderate price variability. This places Kura Oncology within the typical volatility range for Biotechnology.
Standard Deviation | = | SQRT(V) |
| = | 2.97 | |
Standard Deviation Peers Comparison
The peer group averages 5.02 for Standard Deviation, with Kura Oncology at 2.97 falling below that level. Readings span 3.14 (Bicara Therapeutics Common) to 12.08 (Replimune Group). Kura Oncology has exhibited less price dispersion than the peer average over the measured period.
Standard Deviation Relative To Other Indicators
The chart below plots Standard Deviation against Maximum Drawdown for Kura Oncology and its peers. Each point represents one equity — position along the horizontal axis shows Standard Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Kura Oncology's Maximum Drawdown of
13.36 runs about
4.50 times its Standard Deviation of
2.97 . This indicates Maximum Drawdown is significantly higher than Standard Deviation for Kura Oncology.
Methodology, Assumptions & Data Sources
Kura Oncology's Standard Deviation currently stands at 2.97. The Standard Deviation for Kura Oncology applies a standardized calculation to daily closing prices and, where applicable, volume data across the selected period. Price data is sourced from standardized end-of-day feeds across supported exchanges, normalized for corporate actions. Kura Oncology operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Results are based on historical returns and do not predict future performance. This indicator is provided for informational purposes.
Other Technical Indicators